Home Ingredients Bitter Melon (Momordica charantia)
Metabolic Health

Bitter Melon (Momordica charantia)

Momordica charantia
Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Bitter melon (also called bitter gourd, karela) is a tropical vine fruit used as both food and medicine across South Asia, Africa, and the Caribbean. Used for diabetes for centuries. Active compounds include charantin, vicine, polypeptide-p ('plant insulin'), and momordicin. Modest evidence for glycemic improvement in T2DM. Critical caution: contains potential teratogens — avoid during pregnancy. Vicine causes favism in G6PD-deficient individuals.

Studied Dose 1-3 g/day fruit/seed powder; 200-500 mg/day standardized extract; juice 50-100 mL/day
Active Compound Charantin (cucurbitane-type triterpenoids), polypeptide-p ('plant insulin'), vicine, momordicin

Benefits

T2DM Glycemic Modest Improvement

Multiple trials (especially Cefalu 2008, Fuangchan 2011) show bitter melon modestly reduces fasting glucose and HbA1c in T2DM patients. Effect generally smaller than metformin. Evidence varies by formulation, dose, duration.

Supported by Trial 1, Trial 2

Insulin-Like Effects ('Plant Insulin')

Polypeptide-p has structural similarity to insulin and was historically called 'plant insulin' or 'p-insulin' — modest insulin-mimetic activity. Mechanism interesting but clinical effect modest.

Supported by Trial 1, Trial 2

Anti-Inflammatory and Antioxidant

Multiple bitter melon compounds have antioxidant and anti-inflammatory effects in vitro. Modest contribution to overall metabolic benefit.

Supported by Trial 1, Trial 2

Cholesterol Modest Reduction

Some trials show modest cholesterol and triglyceride reduction. Less consistent than glycemic effects.

Supported by Trial 1, Trial 2

Weight Management Adjunct

Modest effects on weight and visceral fat in some trials. Substantially smaller effect than evidence-based weight management interventions.

Supported by Trial 2, Trial 1

Mechanism of action

1

Insulin Receptor Activation

Polypeptide-p and other bitter melon compounds activate insulin receptor signaling — modestly mimicking insulin. Mechanistically interesting.

2

AMPK Activation

Bitter melon activates AMP-activated protein kinase (AMPK) — same target as metformin and exercise. Improves glucose uptake and reduces gluconeogenesis.

3

Alpha-Glucosidase Inhibition

Bitter melon compounds inhibit alpha-glucosidase — reducing carbohydrate digestion and post-prandial glucose. Similar mechanism to acarbose.

4

Charantin Triterpenoid Effects

Charantin (cucurbitane-type triterpenoids) modulates multiple pathways including PPAR-gamma — similar mechanism to thiazolidinedione drugs (pioglitazone). Improves insulin sensitivity.

Clinical trials

1
Bitter Melon for T2DM

Clinical trial comparing bitter melon (500 mg or 1,000 mg or 2,000 mg/day) vs metformin (1,000 mg/day) in 143 T2DM patients for 4 weeks.

143 T2DM patients.

Bitter melon 2,000 mg/day modestly reduced fructosamine and glucose; effect smaller than metformin. Lower doses showed minimal effect. Established modest dose-dependent glycemic effect.

2
Bitter Melon Cochrane Review (Negative)

Cochrane evidence review of bitter melon for T2DM.

Pooled across T2DM clinical trials.

Insufficient evidence to recommend bitter melon for T2DM; effects modest and inconsistent across trials. Standard T2DM management primary.

Side effects and drug interactions

Common Potential side effects

GI distress (nausea, abdominal pain, diarrhea) — particularly with juice forms.
Hypoglycemia with insulin/sulfonylureas.
Favism in G6PD-DEFICIENT individuals — bitter melon seeds contain vicine (same compound as fava beans) that causes hemolytic anemia in G6PD-deficient people; avoid seeds in this population.
Headache.
Bitter taste — major palatability issue with juice/whole fruit.
Potential TERATOGEN — animal studies suggest abortifacient and teratogenic effects; avoid in pregnancy.
Liver enzyme elevation (rare).

Important Drug interactions

Insulin / sulfonylureas — additive hypoglycemic; monitor closely.
Metformin — generally compatible; modest additive effects.
GLP-1 agonists, SGLT2 inhibitors — modest additive.
Anticoagulants — theoretical bleeding risk at high doses.
Drugs metabolized by CYP enzymes — bitter melon may modestly affect; theoretical interactions.

More Metabolic Health Ingredients

Metabolic Health
Psyllium Husk (Plantago ovata)
Psyllium husk is the soluble fiber derived from the seed husks of Plantago ovata — the mos…
Metabolic Health
Thiamine
Thiamine, also known as vitamin B1, is a water-soluble vitamin essential for converting ca…
Metabolic Health
Berberine
Berberine is a bioactive compound extracted from plants like barberry and goldenseal, know…
Metabolic Health
Inositol (Myo-Inositol)
Inositol is a naturally occurring sugar alcohol that acts as a secondary messenger in insu…

Related articles from our blog

📝 Article
🌿 Natural Blood Sugar Support: A Herbal Solution for Balanced Glucose
If you're looking for a natural, plant-based way to support healthy blood sugar levels , you're not alone. With diabetes…
June 12, 2025
📝 Article
What to Take With Ozempic & GLP-1 Medications (Without Losing Muscle)
GLP-1 medications, including semaglutide (Ozempic, Wegovy, and the oral pill Rybelsus), tirzepatide (Mounjaro, Zepbound)…

Frequently asked questions about Bitter Melon (Momordica charantia)

What is bitter melon used for?

Bitter melon is a tropical vegetable used, especially in Asian traditions, for blood-sugar support. It contains compounds with insulin-like and glucose-lowering activity, and is eaten as a food or taken as juice or extract.

Does bitter melon help with blood sugar?

Bitter melon is traditionally and in some studies used to support healthy blood sugar, with several compounds that may improve glucose uptake. Evidence is mixed and effects modest, so it is supportive rather than a treatment.

How much bitter melon should I take?

It is eaten as a vegetable, drunk as juice, or taken as a standardized extract; follow product labeling. It is intensely bitter, hence the name. Take it with meals for blood-sugar goals.

Is bitter melon safe?

As a food it is safe. As a concentrated supplement it can lower blood sugar, so those on diabetes medication should monitor and check with a doctor. Pregnant women should avoid medicinal amounts, as it has traditional reproductive cautions.

What is Bitter Melon?

Bitter melon (also called bitter gourd, karela) is a tropical vine fruit used as both food and medicine across South Asia, Africa, and the Caribbean. Used for diabetes for centuries. Active compounds include charantin, vicine, polypeptide-p ('plant insulin'), and momordicin.

What is the recommended dosage of Bitter Melon?

The clinically studied dose is 1-3 g/day fruit/seed powder; 200-500 mg/day standardized extract; juice 50-100 mL/day Always follow the product label and check with a healthcare provider for personal advice.

Is Bitter Melon safe, and does it have side effects?

For most healthy adults, Bitter Melon is well tolerated at studied doses. Reported effects can include: GI distress (nausea, abdominal pain, diarrhea) — particularly with juice forms. Hypoglycemia with insulin/sulfonylureas. It may also interact with some medications. Bitter Melon is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Bitter Melon interact with any medications?

Possible interactions include: Insulin / sulfonylureas — additive hypoglycemic; monitor closely. Metformin — generally compatible; modest additive effects. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Bitter Melon?

NutraSmarts rates the evidence for Bitter Melon as Limited (2 out of 5). It is backed by 2 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Zhang X, Zhao Y, Song Y, Miao M Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials Heliyon. 2024;10(10):e31126. doi: 10.1016/j.heliyon.2024.e31126.PubMedUsed to support: Systematic review and meta-analysis of RCTs finding Momordica charantia supplementation produced modest improvements in glycemic control and lipid profiles in T2DM patients; backs 'T2DM Glycemic Modest Improvement' and 'Cholesterol Modest Reduction'.
  2. Cortez-Navarrete M, Martínez-Abundis E, Pérez-Rubio KG, González-Ortiz M, Méndez-Del Villar M Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus Journal of Medicinal Food. 2018;21(7):672-677. doi: 10.1089/jmf.2017.0114.PubMedUsed to support: Human clinical study showing Momordica charantia administration improved insulin secretion in patients with T2DM; backs 'Insulin-Like Effects' and 'T2DM Glycemic Modest Improvement'.
  3. Mkhize SAL, Phoswa WN, Ngubane PS, Mokgalaboni K Efficacy of Momordica charantia in glycaemic control and insulin resistance among patients with prediabetes and type 2 diabetes. A GRADE-adherent meta-analysis of randomised controlled trials Metabolism Open. 2025;28:100407. doi: 10.1016/j.metop.2025.100407.PubMedUsed to support: Grade-adherent meta-analysis of RCTs assessing Momordica charantia for glycemic control and insulin resistance in prediabetes and T2DM; backs 'T2DM Glycemic Modest Improvement' and 'Insulin-Like Effects'.